Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.
Ontology highlight
ABSTRACT: Microglia, the innate immune cells of the CNS, perform critical inflammatory and noninflammatory functions that maintain normal neural function. For example, microglia clear misfolded proteins, elaborate trophic factors, and regulate and terminate toxic inflammation. In Alzheimer's disease (AD), however, beneficial microglial functions become impaired, accelerating synaptic and neuronal loss. Better understanding of the molecular mechanisms that contribute to microglial dysfunction is an important objective for identifying potential strategies to delay progression to AD. The inflammatory cyclooxygenase/prostaglandin E2 (COX/PGE2) pathway has been implicated in preclinical AD development, both in human epidemiology studies and in transgenic rodent models of AD. Here, we evaluated murine mod
SUBMITTER: Johansson JU
PROVIDER: S-EPMC4382270 | biostudies-literature | 2015 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA